Rheumatoid generally refers to rheumatoid arthritis, and the early stage of the disease is treated mainly with non-surgical treatment. Patients should first establish the belief of long-term struggle with the disease, avoid various triggering factors, and appropriate rest, physical therapy, body therapy, correct joint activities and muscle exercises have a role in relieving symptoms and improving joint function, which need to be carried out under the guidance of physicians. There is no cure for rheumatoid arthritis. The goal of treatment is to control symptoms, prevent structural damage, restore physiological function and improve daily living ability, and maximize the quality of health-related survival. The most important way to achieve treatment goals is to eliminate inflammation, emphasizing the principles of early treatment, combination of drugs and individualized therapy. General treatment includes patient education, rest, joint braking (acute phase), functional joint exercise (recovery phase), and physical therapy. Bed rest is only appropriate for patients in the acute phase, fever, and those with internal organ involvement. Drug therapy is divided into five main categories, namely, non-steroidal anti-inflammatory drugs, disease-modifying anti-rheumatic drugs, glucocorticoids, botanicals and biological agents. The first group of NSAIDs has analgesic and anti-inflammatory effects and is commonly used to improve the symptoms of arthritis, but cannot control the disease and should be taken together with disease-modifying anti-rheumatic drugs. The second type of disease-modifying anti-rheumatic drugs, these drugs are slower to work than NSAIDs, taking about 1 to 6 months. They do not have obvious analgesic and anti-inflammatory effects, but can slow down or control the progress of the disease. Commonly used drugs include salazosulfapyridine and methotrexate. To compensate for their slow onset and weak anti-inflammatory effect, they can be combined with a non-steroidal anti-inflammatory drug. The third category of glucocorticoids, glucocorticoids can not stop the progression of the disease, and the adverse effects are large, generally not recommended for long-term oral or intravenous treatment, only in severe conditions when short-term use. The fourth category of botanicals, such as thujaplicins, cyanophylline and paeoniflorin, etc. The fifth group of biological agents has good anti-inflammatory and stopping disease progression, and its main characteristics are rapid onset of action, good overall patient tolerance, and significant efficacy in delaying or inhibiting bone destruction. Early application may lead to relief of clinical symptoms and somatic dysfunction in more patients, but this drug has an increased risk of tuberculosis infection, hepatitis virus activation and tumor development, and its use needs to be under the guidance of a clinician. Therefore, there is no cure for rheumatoid at present, but there are many proven clinical treatments to control its absence and achieve a clinical cure. And because rheumatoid arthritis is a heterogeneous disease, drug treatment regimens should be individualized.